5. Observational Study of Routine Use of 9-Valent Human Papillomavirus Vaccine: Safe in More Than 140,000 Individuals

BACKGROUND: Nine-valent human papillomavirus (HPV) vaccine (9vHPV vaccine, Gardasil®9) was licensed in the US in Dec-2014. Using a self-controlled risk interval design, we conducted a post-licensure retrospective cohort study within Kaiser Permanente in Northern California (KPNC) to assess 9vHPV saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, John, Yee, Arnold, Lewis, Ned, Li, Se, Velicer, Christine, Saddier, Patricia, Klein, Nicola P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776038/
http://dx.doi.org/10.1093/ofid/ofaa439.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776038/
http://dx.doi.org/10.1093/ofid/ofaa439.050

Ejemplares similares